4th Quarter - Report

HOSPIRA, INC. for HOSPIRA INC

Firm
Client
Income
—
Expenses
$280,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Implementation of the Biologics Price Competition and Innovation Act (BPCIA)

LobbyistCovered position, as disclosed
JULIANA REED —
WENDY SUSSMAN —

Contacted: SENATE; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Issues related to integrating biosimilar medications into the Medicare and Medicaid programs; issues related to creating a new marketplace for biosimilar medications in the United States.

LobbyistCovered position, as disclosed
JULIANA REED —
WENDY SUSSMAN —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS)

Pharmacy PHA

Issues relating to opioid abuse and drug shortages; Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products Proposed Rule by FDA (RIN:0910-AG94)

LobbyistCovered position, as disclosed
JULIANA REED —
WENDY SUSSMAN —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.